Glanbia plc (ISE:GL9)
Ireland · Delayed Price · Currency is EUR | Market Cap | 4.24B +47.9% |
| Revenue (ttm) | 3.36B +2.8% |
| Net Income | 156.06M +11.3% |
| EPS | 0.62 +16.0% |
| Shares Out | 242.10M |
| PE Ratio | 28.41 |
| Forward PE | 14.19 |
| Dividend | 0.37 (2.12%) |
| Ex-Dividend Date | Mar 19, 2026 |
| Volume | 478,368 |
| Average Volume | 943,678 |
| Open | 17.50 |
| Previous Close | 17.52 |
| Day's Range | 17.33 - 17.69 |
| 52-Week Range | 9.20 - 17.67 |
| Beta | 0.46 |
| RSI | 63.57 |
| Earnings Date | Feb 25, 2026 |
About Glanbia
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing business; property and land dealing business; property leasing; provision of business services a... [Read more]
Financial Performance
In fiscal year 2025, Glanbia's revenue was $3.95 billion, an increase of 2.78% compared to the previous year's $3.84 billion. Earnings were $183.30 million, an increase of 11.29%.
Financial numbers in USD Financial StatementsNews
Glanbia’s Kilkenny headquarters is on the market for €2.95m
The headquarters of global nutrition company, Glanbia, has hit the market with a guide price of €2.95m.
Glanbia PLC (GLAPF) Full Year 2025 Earnings Call Highlights: Navigating Growth Amidst Cost ...
Glanbia PLC (GLAPF) Full Year 2025 Earnings Call Highlights: Navigating Growth Amidst Cost Challenges
Full Year 2025 Glanbia PLC Earnings Call Transcript
Full Year 2025 Glanbia PLC Earnings Call Transcript
Glanbia has ‘no plans’ to shift listing to US, as sales there rise
Glanbia has no plans to shift its primary share listing to the United States, even as its key Performance Nutrition division sees growth acceleration there, according to chief financial officer Mark G...
Glanbia has ‘no plans’ to list in New York, says CFO Mark Garvey, despite rise in US sales
Glanbia has no plans to shift its primary stock market listing to the United States, even as its key performance nutrition division sees growth acceleration in the US, according to chief financial off...
Glanbia PLC (DUB:GL9) Q4 2025 Earnings Report Preview: What To Look For
Glanbia PLC (DUB:GL9) Q4 2025 Earnings Report Preview: What To Look For
The week ahead in business: Hoteliers voice concern about Irish economy as Diageo and Glanbia publish figures
Concerns about global instability and rising business costs will be in focus today as the Irish Hotels Federation (IHF) gathers for its 88th Annual Conference at the Gleneagle Hotel, Co Kerry.
Glanbia to sell Slimfast US to Heartland Food Products group of US
Irish-based nutrition supplement maker Glanbia on Wednesday said it had agreed to sell its weight management brand SlimFast US to Heartland Food Products Group for an undisclosed sum.
Flax Protein Markets and Companies Analysis Report 2025 with Forecasts to 2029 & 2034 - Featuring Glanbia Nutritionals, Grain Millers, Myprotein, Linwoods Health Foods, Bioriginal Food & Science Corp. and More
Explore the booming Flax Protein Market: projected to soar from $38.54B in 2024 to $56.42B by 2029, driven by the rise in plant-based diets and demand for minimally processed foods. Explore the boomin...
Glanbia shares jump after 'better than feared' first quarter
Shares in nutrition supplement maker Glanbia jumped 10% on Wednesday after analysts pointed to a "better than feared" first quarter performance that allowed the Irish group to maintain its full year e...
Supplements producer Glanbia's shares dive on profit warning
Shares in nutrition supplement maker Glanbia slid by 15% on Wednesday after it warned that it expects earnings to fall by up to 11% this year, hit by a longer than expected rise in the cost of whey, a...